This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.80% per year. These returns cover a period from January 1, 1988 through August 3, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View the Zacks #1 Rank List
Zacks News
ETF Sectors to Bet on Positive Vaccine News
by Sweta Jaiswal, FRM
The introduction of the coronavirus vaccine is expected to help in the economic recovery, especially for sectors which have taken a hit from the social-distancing and lockdown measures.
Time to Rotate to Cyclical Sector ETFs?
by Sanghamitra Saha
U.S. stocks have been super steady this week on Pfizer's upbeat vaccine data and chances of a divided Congress in the United States.
Should You Invest in the Fidelity MSCI Energy Index ETF (FENY)?
by Zacks Equity Research
Sector ETF report for FENY
ETFs Riding the Latest Coronavirus Vaccine Optimism Wave
by Sweta Jaiswal, FRM
The coronavirus vaccine progress has brought back optimism for some ETFs, which were largely affected by the outbreak-led slowdown in economic activities.
Should You Invest in the Fidelity MSCI Energy Index ETF (FENY)?
by Zacks Equity Research
Sector ETF report for FENY
Energy ETFs in Focus Post Exxon, Chevron Earnings
by Sweta Killa
Earnings from the two U.S. supermajor oil producers, namely Exxon Mobil and Chevron disappointed investors.
Will Coronavirus Vaccine & Treatment Optimism Drive These ETFs?
by Sweta Jaiswal, FRM
The coronavirus vaccine and treatment progress can bring back optimism for some ETFs, which are largely affected by the outbreak-led slowdown in economic activities.
Should You Buy Energy ETFs Ahead of Q3 Earnings
by Sweta Killa
Exxon Mobil and Chevron saw positive earnings estimate revisions before the earnings announcement.
Should You Invest in the Fidelity MSCI Energy Index ETF (FENY)?
by Zacks Equity Research
Sector ETF report for FENY
Should You Invest in the Fidelity MSCI Energy Index ETF (FENY)?
by Zacks Equity Research
Sector ETF report for FENY